author-photo

Bruno Cazin

Lille University of Science and Technology

68

Papers

3842

Citations

Citation Trend

Filter By

Papers (47) Sort By

Journal Conference Others

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (15)
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.

2015 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (20)
First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in “ultra High-risk” CLL: Final Results from the CLL2O Phase II Study

2014 Blood
Show All
- Source
- Cite
- Save
Citations (9)
Bendamustine, Ofatumumab and High-Dose Methylprednisolone (BOMP) in Relapsed/Refractory CLL: Results of a Planned Interim Analysis of the French CLL Intergroup ICLL01 Phase II Trial

2014 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Updated Follow-Up In The CLL2007FMP Trial Supports The Non Superiority Of The Association Fludarabine-Cyclophosphamide (FC) Plus Campath Compared To FC Plus Rituximab and Points Out The Importance Of Minimal Residual Disease, By 6-Color Flow Cytometry Technique, On Progression Free Survival

2013 Blood
Show All
- Source
- Cite
- Save
Citations (0)
First immunochemotherapy outcomes in elderly patients with CLL: A retrospective analysis

2013 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia

2013 Haematologica
Show All
- Source
- Cite
- Save
Citations (36)